CD133 Innovation Limited is committed to pursuing a precise and sensitive detection of circulating tumour cells (CTC) through our bio-imaging technology together with the current early cancer detection method.
Neurostem imaging is our company designed magnetic nano-sized contrast agent. Our technology enables the visualisation of target cells or neural stem cells precisely, also makes real-time cell tracking possible under Magnetic Resonance Imaging. With our strategic designed nanoparticles, the detection sensitivity of CTC could be highly enhanced, thus providing a significant prognostic information for patients.
Company Details
- Founded
- 2018
- Address
- 1008, Cyberport 1, Telegraph Bay, Hong Kong,hong Kong Sar 852,hong Kong
- Industry
- Biotechnology
- Website
- http://www.cd133inno.com
- Keywords
- Kowloon.
- HQ
- Hong Kong , Hong Kong SAR
- Competitors
- Konew FinTech Corporation Limited, Unicorn Capital Partners 獨秀資本, Jockey Club Design Institute for Social Innovation, Octagon Capital Advisors, Finesse Intelligent Tech (FIT), Knowledge Transfer and Entrepreneurship Office (KTEO), PolyU, TOPPAN Edge (Hong Kong) Limited, 中港網絡安全協會 HKCNSA, Cloud Systems Asia Ltd, Butler Asia.
Cd133 Innovation Questions
Cd133 Innovation's website is http://www.cd133inno.com
Cd133 Innovation's LinkedIn profile is https://hk.linkedin.com/company/cd133-innovation
Cd133 Innovation's industry is
Biotechnology
Cd133 Innovation's top competitors are
Konew Fintech Corporation Limited,
Unicorn Capital Partners 獨秀資本,
Jockey Club Design Institute For Social Innovation,
Octagon Capital Advisors,
Finesse Intelligent Tech (Fit),
Knowledge Transfer And Entrepreneurship Office (Kteo), Polyu,
Toppan Edge (Hong Kong) Limited,
中港網絡安全協會 Hkcnsa,
Cloud Systems Asia Ltd,
Butler Asia.
Cd133 Innovation's categories are Biotechnology
Cd133 Innovation's founding year is 2018
